Published in Trans Am Soc Artif Intern Organs on January 01, 1974
First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med (2005) 1.14
[The use of perftoran in clinical medicine]. Anesteziol Reanimatol (1996) 1.01
Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull Exp Biol Med (2003) 1.00
Problems of artificial hearts and their experimental study. J Thorac Cardiovasc Surg (1969) 0.87
[The role of the metabolic status of the donor and the recipient in survival of a skin graft according to histological data]. Fiziol Cheloveka (2004) 0.81
Importance of adsorption-desorption processes of plasma proteins in biomaterials hemocompatibility. Trans Am Soc Artif Intern Organs (1984) 0.78
[Surgical technic of testicular transplantation]. Vestn Khir Im I I Grek (1978) 0.77
Cell transplantation inhibits inflammatory reaction and stimulates repair processes in burn wound. Bull Exp Biol Med (2006) 0.77
Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluations. J Thorac Cardiovasc Surg (1987) 0.77
ElastoPHB membrane systems with immobilized bone marrow stromal cells optimize conditions for regeneration of damaged tissue. Bull Exp Biol Med (2005) 0.76
[The use of pre-differentiated mesenchymal bone marrow stem cells for treatment of deep burn wounds]. Vestn Khir Im I I Grek (2003) 0.76
Use of autologous bone marrow mesenchymal stem cells for healing of free full-thickness skin graft in a zone with pronounced hypoperfusion of soft tissues caused by arteriovenous shunting. Bull Exp Biol Med (2006) 0.76
[A comparative study of the dynamics of deep burns healing in using medullary allogenic fibroblast-like mesenchymal stem cells from bone marrow immobilized on biodegrading membranes or taken from cultural plastic]. Patol Fiziol Eksp Ter (2005) 0.76
[Effect of alpha-tocopherol acetate and sodium selenite on the change in ATP content and the RNA synthesis rate in the ischemic myocardium]. Farmakol Toksikol (1979) 0.75
[Experience in using preserved xenogeneic hepatocytes in the combined treatment of jaundice patients]. Vestn Khir Im I I Grek (1991) 0.75
[Relationship of immune imbalance with the development of multiple organ failure in patients with complicated postoperative period after the cardiac surgery]. Anesteziol Reanimatol (2003) 0.75
[Potentiation of the anti-ischemic effect of cardioplegic solutions by phosphorylated metabolites]. Kardiologiia (1987) 0.75
[Kidney preservation by a nonperfusion method]. Khirurgiia (Mosk) (1982) 0.75
[Mesenchymal stem cells transplantation in the treatment of radiation skin lesions]. Patol Fiziol Eksp Ter (2011) 0.75
[Improvement of myocardial remodelling and functioning in patients undergoing surgical treatment of chronic cardiac insufficiency by two-staged elevation of the immunoregulatory reserve of autological bone marrow cells and their intramyocardial application]. Vestn Ross Akad Med Nauk (2008) 0.75
[Pharmacological protection of the kidneys from ischemic damage. The effectiveness of anti-ischemia protection of the kidneys in simulating the terminal state in the donors]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Equipment for blood detoxication in critical care of patients]. Med Tekh (1995) 0.75
[Approaches to the left cardiac valves and conditions of their surgical treatment under extracorporeal circulation]. Grudn Khir (1967) 0.75
[Correction of cytokine imbalance and stimulation of regeneration of indolent autoimmune gastric ulcers in transplantation of a stromal fraction of autologous bone marrow cells]. Patol Fiziol Eksp Ter (2009) 0.75
[Mechanisms of correcting acid-base, ionic and osmotic homeostasis in a heart-lung preparation with inclusion of isolated kidneys]. Fiziol Zh (1985) 0.75
[Roenteen diagnosis of various forms of mitral valve defects in the light of indications for various surgical interventions]. Grudn Khir (1969) 0.75
[Problems of organ preservation]. Khirurgiia (Mosk) (1979) 0.75
[Diabetic complications in rats in long-term modeling of type I diabetes mellitus]. Patol Fiziol Eksp Ter (2007) 0.75
[Use of precultivative multipotent mesenchymal stromal cells isolated from autologic bone marrow in treatment of non-healing autoimmune gastric ulcers]. Khirurgiia (Mosk) (2009) 0.75
[Influence of cell therapy and alimentary correction on the condition of microcirculatory system in experimental dyslipidemia]. Patol Fiziol Eksp Ter (2006) 0.75
[Experimental substantiation of the efficiency of using the stem and progenitory cells of the bone marrow for regulating the recovery processes in organs in acute and chronic affections]. Vestn Ross Akad Med Nauk (2004) 0.75
[Artificial ball valves of the heart]. Khirurgiia (Mosk) (1966) 0.75
[Possibility of the restoration of kidney function after critical periods of thermal ischemia by perfusion]. Vestn Akad Med Nauk SSSR (1985) 0.75
[Problems of pharmacological protection of the kidneys during transplantation]. Vestn Akad Med Nauk SSSR (1981) 0.75
[Acid-base equilibrium disorders in chronic renal insufficiency]. Klin Med (Mosk) (1969) 0.75
[Functional activity of placental, splenic and hepatic tissues in pyo-septic diseases under conditions of extracorporeal detoxication]. Khirurgiia (Mosk) (1998) 0.75
[Effect of rapid cooling on the viability of rats in the terminal stage of hemorrhagic shock]. Klin Khir (1988) 0.75
[Regenerative cell therapy of the type I diabetes mellitus and its complications]. Vestn Ross Akad Med Nauk (2008) 0.75
[Pharmacologic protection of the kidneys from ischaemic damage. Mechanism of achievement of anti-ischemic protection of donor kidneys with drugs from different pharmacologic groups]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Artificial heart implanted in the thoracic cavity]. Kardiologiia (1967) 0.75
Use of recombinant AdSV40-BetaGal adenoviral construction for monitoring of transplanted cells. Bull Exp Biol Med (2005) 0.75
[Inflammation and apoptosis in relation with the effectiveness of bone marrow cell transplantation to patients with chronic heart failure]. Vestn Ross Akad Med Nauk (2006) 0.75
[Permissible time of the hypothermic perfusion of the kidneys with albumin-salt solutions]. Vestn Akad Med Nauk SSSR (1985) 0.75
[Effect of chronic denervation on blood flow and ultrastructural and functional status of the tubule system of the solitary kidney]. Fiziol Zh (1990) 0.75
[Total energy debt as a measure of the reversibility of terminal states of the body]. Vestn Akad Med Nauk SSSR (1976) 0.75
[A method of determining in a living animal the dynamics of tracer glucose oxidation in a sanitary-toxicologic experiment]. Gig Sanit (1975) 0.75
[An experimental study of the energy metabolism in the cortex of the single denervated kidney]. Urol Nefrol (Mosk) (1991) 0.75
[Cell technologies and modern medicine]. Patol Fiziol Eksp Ter (2004) 0.75
[The problem of thrombus formation on prosthetics in various sections of the cardiovascular system (review of data in foreign literature)]. Grudn Khir (1969) 0.75
[Cell therapy as a method to correct pathogenetic disturbances in dyslipidemia and early atherosclerosis]. Vestn Ross Akad Med Nauk (2006) 0.75
[Mechanisms of myocardial protection and damage under the effects of cardioplegic solutions]. Kardiologiia (1983) 0.75
[Functional activity of the hepatocytes in the liver fragments in vitro: dependence on the sizes of fragments and duration of their cultivation]. Biull Eksp Biol Med (1997) 0.75
[Multiple organ failure as a manifestation of immune dysregulation of reparative processes in the organs during critical states]. Anesteziol Reanimatol (2001) 0.75
[Effect of perfluorocarbon emulsions on the protective properties of cardioplegic solutions]. Biull Eksp Biol Med (1986) 0.75
[Changes in the local blood flows of the single kidney with partial impairment of the autonomic innervation]. Biull Eksp Biol Med (1989) 0.75
[Use of a differential calorimetry method for studying the energy mechanisms of the protective action of anti-ischemic agents]. Farmakol Toksikol (1984) 0.75
[Action of vitamin E on the normal myocardial energy balance and in ischemia and reoxygenation]. Farmakol Toksikol (1986) 0.75
[Hemoperfusion via cryopreserved tissue fragments of xenogeneic spleen in suppurative-septic states in urology]. Urol Nefrol (Mosk) (1991) 0.75
[Problem of automatic control of the artificial heart and mathematical modeling]. Khirurgiia (Mosk) (1968) 0.75
[Non-perfusion method of kidney preservation under clinical conditions with the aid of a special solution]. Khirurgiia (Mosk) (1974) 0.75
[Mechanism of anti-ischemic kidney protection by preparations of different pharmacologic groups]. Patol Fiziol Eksp Ter (1981) 0.75
[Optimal conditions for preservation of isolated heart using creatine phosphate and vitamin E (an experimental study)]. Biull Eksp Biol Med (1990) 0.75
[Cytokine imbalance correction and regeneration stimulation of persistent autoimmune stomach ulcers with help of periulcer transplantation of mononuclear cells of autological bone marrow]. Eksp Klin Gastroenterol (2009) 0.75
[Total energy deficit as a measure of reversibility of terminal states of the body]. Anesteziol Reanimatol (1977) 0.75
[Treatment of severe hepatic insufficiency by perfusion of patients' blood through a suspension of cryopreserved hepatocytes]. Khirurgiia (Mosk) (1990) 0.75
[Morphologic criteria for kidney preservation]. Biull Eksp Biol Med (1981) 0.75
[Ion-balanced cardioplegic solutions in cardiac surgery]. Vestn Khir Im I I Grek (1989) 0.75
[Artificial heart implanted into the organism]. Kardiologiia (1967) 0.75
[Implanted artificial heart ventricle]. Grudn Khir (1968) 0.75
[On the radiologic study of the function of artificial valves in heart defects]. Kardiologiia (1967) 0.75
[Dynamic activity of the splenic lymphocytes during the modelling of chronic denervation-delymphatization of the kidneys in mice]. Biull Eksp Biol Med (1988) 0.75
Differentiation of bone marrow stromal stem cells into cardiomyocyte-like cells in different mammalian species. Bull Exp Biol Med (2003) 0.75
[Artificial heart valves with an instrument for sutureless mechanical installation]. Grudn Khir (1968) 0.75
[Dynamic analysis of circulatory gas and ion composition]. Eksp Khir Anesteziol (1969) 0.75
[The use of fragments of a xenospleen in an extracorporeal perfusion system for detoxication and correction of immune disorders in patients with diffuse peritonitis]. Anesteziol Reanimatol (1992) 0.75
[Anti-ischemic protection of the myocardium by cardioplegic solutions]. Vestn Akad Med Nauk SSSR (1985) 0.75
[Stabilizing effect of the antioxidants alpha-tocopherol and sodium selenite following phospholipase damage to mitochondrial membranes in a model of anoxia]. Farmakol Toksikol (1979) 0.75
[Development and application of new biomedical technologies in the diagnosis and treatment of cardiovascular diseases]. Vestn Ross Akad Med Nauk (2003) 0.75
[The use of perfluorocarbon emulsions for suppression of rejection reaction in kidney allotransplantation]. Khirurgiia (Mosk) (1993) 0.75
[Ways of increasing the protective effect of cardioplegic solutions]. Kardiologiia (1984) 0.75
[Controlled production of active oxygen forms by leukocytes allows prognosis of the body resistance to stress damage]. Patol Fiziol Eksp Ter (2007) 0.75
[Use of perfluorocarbon emulsion in kidney transplantation]. Khirurgiia (Mosk) (1990) 0.75
[Use of balloon catheters for intraoperative control of resting myocardial pressure during cardioplegia]. Biull Eksp Biol Med (1984) 0.75
[Expediency of administration of fluorocarbon emulsion into the body of a cadaveric donor before taking the kidneys for transplantation]. Vestn Khir Im I I Grek (1989) 0.75
[The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments]. Ter Arkh (1995) 0.75
[Injuries of the left inguinal region and thigh]. Klin Khir (1988) 0.75
[Phonocardiographic study of patients with a spherical prosthesis implanted in the left venous orifice]. Kardiologiia (1967) 0.75
[Transposition of autologous cultivated bone marrow cells promotes prevention and treatment of immunodependent complications in cardiosurgical patients]. Patol Fiziol Eksp Ter (2007) 0.75
[Multipotent mesenchymal stromal cells of the autologous bone marrow accelerate healing indolent gastric ulcers]. Vestn Khir Im I I Grek (2009) 0.75
[Correction of cronic liver failure by transplantation of liver cells suspension and cell-engineering designs (experimental investigation)]. Vestn Ross Akad Med Nauk (2013) 0.75
[The cultivation of bone marrow cells and cell lines on polymeric films]. Biomed Khim (2012) 0.75
[Measurement of the activity of K ions in biological liquids]. Biofizika (1970) 0.75
An isocratic, reversed-phase HPLC method for the determination of postischemic efflux of purines and pyrimidines during reperfusion of isolated liver. Biochemistry (Mosc) (1998) 0.75
[Dynamics of the change in pCl of the myocardium during ischemia]. Biofizika (1970) 0.75
[Effect of vitamin E on the energy allowance of functional and plastic processes in the myocardium during ischemia and reoxygenation]. Farmakol Toksikol (1988) 0.75
Dyslipidogenic microangiopathy in guinea pigs at early stages of atherogenesis. Bull Exp Biol Med (2003) 0.75
[The importance of studies of calcium reabsorption and of the capacity of the blood plasma to inhibit Ca-ATPase activity for the diagnosis of the activity of the inflammatory process and for the prognosis of tubular function in patients with chronic pyelonephritis]. Urol Nefrol (Mosk) (1994) 0.75
[Hypothermia as a damaging factor in heart preservation]. Patol Fiziol Eksp Ter (1991) 0.75
[Comparative evaluation of the effectiveness of the preparations of different pharmacological groups used for pharmacological protection of the kidneys form ischemic damage]. Vestn Akad Med Nauk SSSR (1981) 0.75